The effectiveness of a body mass reduction program in obese women in perimenopausal and menopausal age compared with the effectiveness of such a program in younger (18-44 years of age) women living in Poland

Central European Journal of Public Health

Volumn 13, Issue 1, 2005, Pages 40-46

  Ostrowska, L ^a   Lech, M M ^b,c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Centre for Postgraduate Education   (Poland)

^c School of Public Health   (Poland)

Author keywords

Body mass reduction; Effectiveness; Menopause; Obesity; Observational study

Indexed keywords

ADULT; ARTICLE; BODY MASS; CALORIC RESTRICTION; CARDIOVASCULAR RISK; CLIMACTERIUM; CLINICAL OBSERVATION; DIETARY INTAKE; EXERCISE; FEMALE; HEALTH PROGRAM; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; MOTIVATION; OBESITY; POLAND; QUALITY OF LIFE; SOCIAL SUPPORT; SUBSTITUTION THERAPY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTI-OBESITY AGENTS; COMBINED MODALITY THERAPY; ENERGY INTAKE; EXERCISE; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; OBESITY; PERIMENOPAUSE; POLAND;

EID: 17144369516     PISSN: 12107778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Laurier D, Guiguet M, Chau NP: Prevalence of obesity: a comparative survey in France, the United Kingdom and the United States. Int J Obes 1992;16:565-72.
2. Flegal KM, Caroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes 1998;22:39-47.
3. Kuczmarski RL, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of over-weight among US adults. JAMA 1994;272:205-211.
4. Program Pol-MONICA Warszawa. Kompleksowa ocena stanu zdrowia ludności Warszawy w roku 1993 i jego zmian w latach 1984-1990. Czȩść V. Inst Kardiologii, Warszawa 1995 (in Polish).
5. Porównanie sytuacji zdrowotnej ludności Polski i wybranych krajów europejskich w roku 1996. GUS, 1998 (in Polish).
6. Field AE, Coakley EH, Must A: Impact of overweight on the risk developing common chronic diseases during a 10-year period. Arch Int Med 2001;161:1581-3.
7. Poehlman ET, Tchernof A: Traversing the menopause: changes in energy expenditure and body composition. Coron Artery Dis 1998;9(12):799-803.
8. Wing RR, Mathews KA, Kuller LH, Meilahn EN, Plantinga PL: Weight gain at the time of menopause. Arch Intern Med 1991;151(1):97-102.
9. Stevens J, Cai J, Pamuk ER: The effect of age on the association between body-mass index and mortality. NEJM 1998;338:1-7.
10. Wee CC, McCarthy EP, Davis RB, Philips RS: Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care? Ann Intern Med 2000;132:697-704.
11. MilewiczA: Wybrane endokrynologiczne aspekty otyłości pokarmowej. Endokr Pol 2001;52(3Suppl 1):79-85 (in Polish).
12. Simkin-Silverman LR, Laurey R, Meilahn EN. et al: Women's Health Lifestyle Project: A randomized clinical trial: Results at 54 months. Circulation 2001;103(1):32-37.
13. Pertyński T, Połać I: Otyłość u kobiet w okresie pomenopauzalnym, Menopauza - Sympozjum Menopauza 2000, Łódź 9-11 marca 2002, Instytut Centrum Zdrowia Matki Polki - Bibl Nauk Tom III, Wyd ADI, 2000 (in Polish).
14. Lech M: Refundacja programów redukcji masy ciała jako inwestycja w zdrowie Endokr Pol 2001;52(3-Suppl I):161 (in Polish).
15. Espeland MA, Stefanick MI, Kritz-Silverstein: Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endicrinol Metab 1997;82(5):I549-56.
16. Walsh KM, Leen E, Lean MEJ. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females. Int J Obes 1999;23:1009-15.
17. Gambacciani M, Ciaponi M, Cappagli B, De Simone L: Prospective evaluation of body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 2001;39:125-132.
18. Zahorska-Markiewicz B. An information on the Project ordered by the Ministry of Health and the State Committee for Scientific Research, "Optimisation of therapeutic management in obese persons, based on phenotype features - results of metabolic, psychological and anthropometric studies". Endokr Pol 2001;52(3-Suppl 1):242.
19. Glazer G: Long-term pharmacotherapy of obesity 2000. A review of efficacy and safety. Arch Intern Med 2001;161:1814-24.
20. Lukaski HC: Methods for the assessment of the human body composition: traditional and new. Amer J Clin Nutr 1987;46:537-56.
21. Segal KR, Van Loan M, Fitzgerald PI: Lean body mass estimation by bioelectrical impedance analysis - a four site cross-validation study. Amer J Clin Nutr 1988;47:7-14 (in Polish).
22. Allison DB, Fontaine KR, Manson JE: Annual deaths attributable to obesity in the United States. JAMA 2000;282:1530-8.
23. Simkin-Silverman LR, Wing RR: Weight gain during menopause. Postgrad Med 2000;108(3):47-50.
24. Cox-Reijven PL, Soeters PB: Validation of bio-impedance spectroscopy: Effect of degree of obesity and way of calculating volumes from measured resistance values. Int J Obes 2000;24:271-280.
25. Pietrobelli A, Nunez C, Zingaretti G, et al: Assessment by bioimpedance of forearm cell mass: a new approach to calibration. Eur J Clin Nutr 2002;56:723-28.
26. Olszaniecka-Glinianowicz M, Zahorska-Markiewicz B, Skubacz M: Wpływ trzymiesiȩcznej kompleksowej kuracji odchudzaja̧cej na identyfikacjȩ zachowań żywieniowych otyłych kobiet. Endokr Pol 2001; 52(3-Suppl 1):165 (in Polish).
27. Skalba P, Dyrek B, Urban T: Wybrane wskaźniki gospodarki lipidowej w surowicy krwi otyłych kobiet z zespołem hiperandrogenizacji jajnikowej. Gin Prakt 2002;10(1):43-46 (in Polish).
28. Heymsfield SB, Gallagher D, Poehlman ET, Wolper C, Noas K: Menopausal changes in body composition and energy expenditure. Exper Gerontol 1994;29(3-4):377-389.
29. Ry an AS, Pratley RE, Elahi D: Resistive training increases fat-free mass and maintain RMR despite weight loss in postmenopausal women. Appl Physiol 1995;79(3):818-23.